OpenAI CEO Sam Altman Rules Out 2026 IPO, Citing Escalating AI Safety Risks

SentiSense · Published Sep 12, 2026, 2:04 PM ET · Updated Sep 28, 2026, 2:45 AM ET

Sam Altman told Fortune that taking OpenAI public in 2026 would be "ill-advised" given escalating AI safety concerns. The only thing he committed to is that it will not be 2026; the widely repeated 2027 timeline comes from outlet framing and earlier remarks by CFO Sarah Friar, not a stated OpenAI target. Separately, Anthropic's Dario Amodei published an essay urging labs to slow capability development, and Altman and Elon Musk both publicly backed it.

OpenAI will not pursue an initial public offering in 2026, with chief executive Sam Altman calling a listing "ill-advised" in a Fortune interview published September 12. Altman framed the decision around safety rather than market conditions, saying the company faces "risks we should not be able to incur on behalf of humanity" and that a public debut would be premature.

One widely repeated detail deserves care. Altman committed only to ruling out 2026. The 2027 timeline that appears in much of the coverage traces to CNBC's own framing and to separate August remarks by OpenAI finance chief Sarah Friar, not to a new target the company stated this week. Treat 2027 as an inference, not a plan of record.

The decision landed the same week as a related but separate debate about the pace of AI development. Anthropic co-founder Dario Amodei published an essay arguing that labs should slow the rate at which they push model capabilities, and both Altman and Elon Musk publicly backed Amodei's proposal. The direction of that endorsement runs the opposite way from how it is often summarized: Amodei did not weigh in on OpenAI's IPO timing, and it was Altman and Musk who lined up behind his slow-down argument.

For investors, a non-event on the calendar is still information. OpenAI is the largest private company most public-market AI exposure is priced against, and a deferred listing keeps that exposure indirect, routed through MSFT, NVDA and the rest of the compute supply chain rather than through OpenAI equity itself. The signals worth watching are whether OpenAI publishes a safety roadmap, whether Friar's 2027 framing is ever adopted by the company on the record, and whether the slow-down consensus survives contact with competitive pressure.